Detalhe da pesquisa
1.
An Exploratory Analysis of the "Was It Worth It?" Questionnaire as a Novel Metric to Capture Patient Perceptions of Cancer Treatment.
Value Health
; 25(7): 1081-1086, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35779938
2.
Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2.
Qual Life Res
; 31(4): 1069-1080, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-34420143
3.
Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial.
JAMA
; 327(24): 2413-2422, 2022 06 28.
Artigo
Inglês
| MEDLINE | ID: mdl-35661856
4.
Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
Clin Trials
; 18(1): 104-114, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33258687
5.
The experience of financial toxicity among advanced melanoma patients treated with immunotherapy.
J Psychosoc Oncol
; 39(2): 285-293, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33103948
6.
Correction to: Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2.
Qual Life Res
; 31(4): 1081, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-34635962
7.
Evaluation of different recall periods for the US National Cancer Institute's PRO-CTCAE.
Clin Trials
; 14(3): 255-263, 2017 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-28545337
8.
Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
Health Qual Life Outcomes
; 14: 24, 2016 Feb 19.
Artigo
Inglês
| MEDLINE | ID: mdl-26892667
9.
The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review.
Support Care Cancer
; 24(8): 3669-76, 2016 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27260018
10.
Linguistic validation of the Spanish version of the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
Support Care Cancer
; 24(7): 2843-51, 2016 07.
Artigo
Inglês
| MEDLINE | ID: mdl-26838022
11.
Feasibility and clinical impact of sharing patient-reported symptom toxicities and performance status with clinical investigators during a phase 2 cancer treatment trial.
Clin Trials
; 13(3): 331-7, 2016 06.
Artigo
Inglês
| MEDLINE | ID: mdl-26542025
12.
Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
Qual Life Res
; 23(1): 257-69, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-23868457
13.
Rapid access to mental health professionals with experience in treating cancer-related distress: the American Psychosocial Oncology Referral Helpline.
J Natl Compr Canc Netw
; 11(11): 1358-61, 2013 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-24225969
14.
Frequency, characteristics, and correlates of pain in a pilot study of colorectal cancer survivors 1-10 years post-treatment.
Pain Med
; 14(11): 1673-80, 2013 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-24010414
15.
Financial Toxicity Monitoring in a Randomized Controlled Trial of Patient-Reported Outcomes During Cancer Treatment (Alliance AFT-39).
J Clin Oncol
; 41(29): 4652-4663, 2023 Oct 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37625107
16.
Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048).
J Clin Oncol
; 41(21): 3724-3734, 2023 07 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37270691
17.
Reliability of adverse symptom event reporting by clinicians.
Qual Life Res
; 21(7): 1159-64, 2012 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-21984468
18.
Measurement of affective and activity pain interference using the Brief Pain Inventory (BPI): Cancer and Leukemia Group B 70903.
Pain Med
; 13(11): 1417-24, 2012 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-23110676
19.
Evaluating Treatment Tolerability Using the Toxicity Index With Patient-Reported Outcomes Data.
J Pain Symptom Manage
; 63(2): 311-320, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34371138
20.
Substance abuse in cancer pain.
Curr Pain Headache Rep
; 14(4): 268-75, 2010 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-20499215